Cilansetron

DB04885ExperimentalSmall molecule

Cilansetron is a 5HT-3 antagonist made by Solvay Pharmaceuticals that is currently under trial phase in the EU and US.

Chemical structure of Cilansetron
Mechanism
Curator reviewed
Primary indication
For the treatment of symptoms associated with irritable bowel syndrome.Curator reviewed
Formula / weight
C20H21N3O · 319.4002 g/mol (avg)
Code names
KC-9946

Resolves to

Clinical / RWD
Structure
InChIKeyNCNFDKWULDWJDS-OAHLLOKOSA-NSMILESCC1=NC=CN1C[C@H]1CCC2=C(C3=CC=CC4=C3N2CCC4)C1=O

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
680Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 8 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Cilansetron, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account